GENERIC NAME OF THE MEDICINAL PRODUCT:
B) Tapentadol Extended-Release Tablets 100mg
C) Tapentadol Extended-Release Tablets 150mg
D) Tapentadol Extended-Release Tablets 200mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film coated Extended-Release tablet contains:
Tapentadol Hydrochloride
Equivalent to Tapentadol……….50mg
Excipients………………………………..q.s.
Colour: Titanium Dioxide IP
B) Tapentadol Extended-Release Tablets 100mg
Each film coated Extended-Release tablet contains:
Tapentadol Hydrochloride
Equivalent to Tapentadol………….100mg
Excipients………………………………q.s.
Colour: Lake of quinoline yellow FCF
C) Tapentadol Extended-Release Tablets 150mg
Each film coated Extended-Release tablet contains:
Tapentadol Hydrochloride
Equivalent to Tapentadol……………..150mg
Excipients………………………………………q.s.
Colour: Lake of Erythrosine
D) Tapentadol Extended-Release Tablets 200mg
Each film coated Extended-Release tablet contains:
Tapentadol Hydrochloride
Equivalent to Tapentadol………..200mg
Excipients…………………………………q.s.
Colour: Ferric oxide yellow
THERAPEUTIC INDICATIONS:
CAUTION & SCHEDULE:
Read enclosed leaflet before use.
SCHEDULE: SCHEDULE H: NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
STORAGE & DOSAGE:
Protect from Light.
Dosage: As directed by the Physician.
Tapentadol Extended-Release Tablets 150mg Technical Specification:
Product Name: | Tapentadol Extended-Release Tablets 150mg |
Brand Name: | NUCYRETA ER |
Strength: | 50mg, 100mg, 150mg, 200mg |
Dosage Form: | Tablets (Film coated Extended-Release) |
Route of Administration: | Via Oral Route |
Packing: | 10s, 30s, 100s, 500s |
Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
Documents: | COA, MOA, Stability Studies, GMP |
Therapeutic use: | Opioid Analgesic, Pain killer |
Indication: | Tapentadol tablets are used to treat moderate to severe acute pain (pain that begins suddenly, has a specific cause, and is expected to go away when the cause of the pain is healed). |
Storage: | Store below 30 °C. Protect from Light. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Tapentadol Extended-Release Tablets 150mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Tapentadol Extended-Release Tablets 150mg
Each film coated Extended-Release tablet contains:
Tapentadol Hydrochloride
Equivalent to Tapentadol……….150mg
Excipients………………………………..q.s.
Colour: Lake of Erythrosine
THERAPEUTIC INDICATIONS:
Tapentadol tablets are used to treat moderate to severe acute pain (pain that begins suddenly, has a specific cause, and is expected to go away when the cause of the pain is healed). Tapentadol extended-release tablets are used to treat severe neuropathic pain (pain caused by nerve damage) in people who have diabetes.
CAUTION & SCHEDULE:
CAUTION: SWALLOW WHOLE DO NOT CHEW OR CRUSH.
Read enclosed leaflet before use.
SCHEDULE: SCHEDULE H: NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A registered medical practitioner.
Keep medicine out of reach of children.
STORAGE & DOSAGE:
Storage: Store below 30 °C.
Protect from Light.
Dosage: As directed by the Physician.